TAM-derived IL-6 plays a crucial role in TAM-mediated cancer stem cell enrichment by activating STAT-3 signalling and influencing breast cancer cell migration and angiogenesis [55]; however, its expression was relatively low across all groups (Figure S2). Here, STAT3 is linked to breast carcinoma.